Norges Bank’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-103,311
| Closed | -$332K | – | 1932 |
|
|
2024
Q1 | $332K | Sell |
103,311
-585,839
| -85% | -$1.88M | ﹤0.01% | 1858 |
|
|
2023
Q4 | $3.38M | Sell |
689,150
-116,822
| -14% | -$572K | ﹤0.01% | 1735 |
|
|
2023
Q3 | $4.39M | Hold |
805,972
| – | – | ﹤0.01% | 1704 |
|
|
2023
Q2 | $5.41M | Hold |
805,972
| – | – | ﹤0.01% | 1701 |
|
|
2023
Q1 | $7.12M | Sell |
805,972
-274,249
| -25% | -$2.42M | ﹤0.01% | 1672 |
|
|
2022
Q4 | $8.25M | Hold |
1,080,221
| – | – | ﹤0.01% | 1626 |
|
|
2022
Q3 | $7.69M | Sell |
1,080,221
-45,454
| -4% | -$324K | ﹤0.01% | 1622 |
|
|
2022
Q2 | $9.11M | Buy |
1,125,675
+60,206
| +6% | +$487K | ﹤0.01% | 1594 |
|
|
2022
Q1 | $14.8M | Buy |
1,065,469
+26,846
| +3% | +$373K | ﹤0.01% | 1540 |
|
|
2021
Q4 | $29.1M | Buy |
1,038,623
+68,914
| +7% | +$1.93M | 0.01% | 1256 |
|
|
2021
Q3 | $33M | Buy |
969,709
+54,830
| +6% | +$1.86M | 0.01% | 1151 |
|
|
2021
Q2 | $37.4M | Buy |
914,879
+245,037
| +37% | +$10M | 0.01% | 1136 |
|
|
2021
Q1 | $27M | Sell |
669,842
-158,038
| -19% | -$6.36M | 0.01% | 1351 |
|
|
2020
Q4 | $49M | Sell |
827,880
-97,881
| -11% | -$5.79M | 0.01% | 983 |
|
|
2020
Q3 | $45M | Buy |
925,761
+859,492
| +1,297% | +$41.8M | 0.01% | 895 |
|
|
2020
Q2 | $3.21M | Hold |
66,269
| – | – | ﹤0.01% | 1917 |
|
|
2020
Q1 | $1.84M | Buy |
66,269
+50,000
| +307% | +$1.39M | ﹤0.01% | 1930 |
|
|
2019
Q4 | $487K | Sell |
16,269
-28,731
| -64% | -$860K | ﹤0.01% | 2053 |
|
|
2019
Q3 | $1.39M | Hold |
45,000
| – | – | ﹤0.01% | 2018 |
|
|
2019
Q2 | $2.17M | Buy |
+45,000
| New | +$2.17M | ﹤0.01% | 1993 |
|